|
Diabetes, Vol 43, Issue 5 696-702, Copyright © 1994 by American Diabetes Association
Early changes in postprandial insulin secretion, not in insulin sensitivity, characterize juvenile obesity
C Le Stunff and P Bougneres
Rene Descartes University, U342 INSERM, Saint Vincent de Paul Hospital, Paris, France.
The development of hyperinsulinemia and insulin resistance, both common in
adults with established obesity, was studied in 16 children, weighing 169
+/- 8% ideal body weight who were 12.7 +/- 0.4 years of age with obesity
duration of 0.5-8.5 years and continuous weight gain in excess of normal,
and compared with 11 age-matched normal children. Early in the evolution of
obesity, insulin and C-peptide responses to a normal meal were increased by
76 and 80%. The first insulin peak was higher (613 +/- 53 pmol/ml) than
normal (413 +/- 59 pmol/ml, P < 0.02) and occurred only 50 +/- 7 min
after onset of lunch versus 33 +/- 11 min in normal children (P <
0.0005). Obese patients had a total of 3.0 +/- 0.2 large insulin peaks
within the 6-h period after the lunch versus only 1.5 +/- 0.2 peaks in
normal children (P < 0.0005). In contrast, fasting plasma insulin and
C-peptide levels remained normal during the initial years of obesity, then
increased progressively with duration (r = 0.73, P < 0.001) and degree
(r = 0.59, P < 0.02) of obesity. Insulin sensitivity evaluated as the
rate of glucose uptake during a three-step hyperinsulinemic euglycemic
clamp was comparable in the obese (20 +/- 1.5 mmol.m-2.min-1) and the
normal (21.7 +/- 1.5 mmol.m-2.min-1) children. Initially higher than normal
in obese children, the maximal rate of glucose uptake decreased with both
obesity duration (r = -0.67, P < 0.005) and children's age (r = -0.66, P
< 0.005), indicating the progressive development of insulin
resistance.(ABSTRACT TRUNCATED AT 250 WORDS)

CiteULike Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
J. L. Leahy
Mary, Mary, Quite Contrary, How Do Your {beta}-Cells Fail?
Diabetes,
October 1, 2008;
57(10):
2563 - 2564.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Isganaitis and R. H. Lustig
Fast Food, Central Nervous System Insulin Resistance, and Obesity
Arterioscler. Thromb. Vasc. Biol.,
December 1, 2005;
25(12):
2451 - 2462.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Brandou, J.-F. Brun, and J. Mercier
Limited Accuracy of Surrogates of Insulin Resistance during Puberty in Obese and Lean Children at Risk for Altered Glucoregulation
J. Clin. Endocrinol. Metab.,
February 1, 2005;
90(2):
761 - 767.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Dos Santos, D. Fallin, C. Le Stunff, S. LeFur, and P. Bougneres
INS VNTR is a QTL for the insulin response to oral glucose in obese children
Physiol Genomics,
February 13, 2004;
16(3):
309 - 313.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. I. Goran, G. D. C. Ball, and M. L. Cruz
Obesity and Risk of Type 2 Diabetes and Cardiovascular Disease in Children and Adolescents
J. Clin. Endocrinol. Metab.,
April 1, 2003;
88(4):
1417 - 1427.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. R. Denburg, M. E. Silfen, A. M. Manibo, D. Chin, L. S. Levine, M. Ferin, D. J. McMahon, C. Go, and S. E. Oberfield
Insulin Sensitivity and the Insulin-Like Growth Factor System in Prepubertal Boys with Premature Adrenarche
J. Clin. Endocrinol. Metab.,
December 1, 2002;
87(12):
5604 - 5609.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Bougneres
Genetics of Obesity and Type 2 Diabetes: Tracking Pathogenic Traits During the Predisease Period
Diabetes,
December 1, 2002;
51(90003):
S295 - 303.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Le Fur, C. Le Stunff, and P. Bougneres
Increased Insulin Resistance in Obese Children Who Have Both 972 IRS-1 and 1057 IRS-2 Polymorphisms
Diabetes,
December 1, 2002;
51(90003):
S304 - 307.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Kooptiwut, S. Zraika, A. W. Thorburn, M. E. Dunlop, R. Darwiche, T. W. Kay, J. Proietto, and S. Andrikopoulos
Comparison of Insulin Secretory Function in Two Mouse Models with Different Susceptibility to {beta}-Cell Failure
Endocrinology,
June 1, 2002;
143(6):
2085 - 2092.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Danadian, V. Lewy, J. J. Janosky, and S. Arslanian
Lipolysis in African-American Children: Is It a Metabolic Risk Factor Predisposing to Obesity?
J. Clin. Endocrinol. Metab.,
July 1, 2001;
86(7):
3022 - 3026.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. STANDRIDGE, R. ALEMZADEH, M. ZEMEL, J. KOONTZ, and N. MOUSTAID-MOUSSA
Diazoxide down-regulates leptin and lipid metabolizing enzymes in adipose tissue of Zucker rats
FASEB J,
March 1, 2000;
14(3):
455 - 460.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
T. J. Kieffer and J. F. Habener
The adipoinsular axis: effects of leptin on pancreatic beta -cells
Am J Physiol Endocrinol Metab,
January 1, 2000;
278(1):
E1 - E14.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. C. Carel, C. Le Stunff, L. Condamine, E. Mallet, J. L. Chaussain, P. Adnot, M. Garabédian, and P. Bougnères
Resistance to the Lipolytic Action of Epinephrine: A New Feature of Protein Gs Deficiency
J. Clin. Endocrinol. Metab.,
November 1, 1999;
84(11):
4127 - 4131.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
A. H. Slyper
Childhood Obesity, Adipose Tissue Distribution, and the Pediatric Practitioner
Pediatrics,
July 1, 1998;
102(1):
4e - 4.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
R. Alemzadeh, G. Langley, L. Upchurch, P. Smith, and A. E. Slonim
Beneficial Effect of Diazoxide in Obese Hyperinsulinemic Adults
J. Clin. Endocrinol. Metab.,
June 1, 1998;
83(6):
1911 - 1915.
[Abstract]
[Full Text]
|
 |
|
Copyright © 1994 by the American Diabetes Association.
|
|
| |
|